Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00392912 · ClinicalTrials.gov registry record · NA
Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone
A NA study, sponsored by Michael E. DeBakey VA Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 10
- Enrollment target
NCT00392912: Completed NA study, sponsored by Michael E. DeBakey VA Medical Center.
NCT00392912 is a NA study that has completed, run by Michael E. DeBakey VA Medical Center. The registered enrollment target is 10 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00392912, a NA study, has completed, sponsored by Michael E. DeBakey VA Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
Study Summary
Treatment with testosterone can improve performance on tests of spatial ability in men with low testosterone levels and Alzheimer's disease. Improved performance on these tests may mean an improved ability to get around in one's environment without getting lost or injured. This could have a positive impact on both patients and those who care for them. We will investigate what areas of the brain are involved in these improvements in spatial ability. This will be done using a PET scan, which creates a 3-dimensional image of the brain that can allow us to see how the brain functions.
Interventions
- DRUG AndroGel (Solvay Pharmaceuticals)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-04 |
| Est. Completion | 2010-07 |
| Phase | NA |
What the finished NCT00392912 record still lists
NCT00392912 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which AndroGel (Solvay Pharmaceuticals) is the first listed.
NCT00392912 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00392912 about?
NCT00392912 is a clinical study titled "Effect of Testosterone Therapy in Men With Alzheimer's Disease and Low Testosterone". Treatment with testosterone can improve performance on tests of spatial ability in men with low testosterone levels and Alzheimer's disease. Improved performance on these tests may mean an improved ability to get around in one's environment without getting lost or injured. This could have a positive...
What is the current status of trial NCT00392912?
This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2007-04. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00392912?
The interventions under investigation include: AndroGel (Solvay Pharmaceuticals) (DRUG).
Who is sponsoring clinical trial NCT00392912?
This trial is sponsored by Michael E. DeBakey VA Medical Center, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00392912's enrollment target sits among peer trials
10 1927th of 2000 higher than 26 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia